Dzikowicz Dillon J, Hernandez-Romero Brenda, Wood Nancy, Abar Beau W, Adler David H, Wang Linwei, Zareba Wojciech
School of Nursing, University of Rochester, 601 Elmwood Ave, Rochester, NY, 14642, USA.
Clinical Cardiovascular Research Center, University of Rochester, 601 Elmwood Ave, Rochester, NY, 14642, USA.
Contemp Clin Trials Commun. 2024 Dec 7;43:101410. doi: 10.1016/j.conctc.2024.101410. eCollection 2025 Feb.
Enrolling heart failure (HF) patients in clinical studies is challenging. Emergency department (ED) may use students as research associates programs, such as the University of Rochester Medical Center (URMC) ED Research Associate (EDRA) program, to screen and consent patients for clinical studies. This manuscript examines the effectiveness of the URMC EDRA program in consenting HF patients into a clinical study.
The URMC EDRA program recruited and consented HF patients presenting at URMC's ED. Research associates in the EDRA program identified potential patients based on age (>18 years) and chief complaints indicative of HF. After identifying potential patients, a thorough chart review was conducted, and any uncertainties were discussed with the patient and treating provider before patients were consented into the study. Descriptive statistics were used to assess the program's effectiveness.
Over one fiscal year, the URMC EDRA program screened 1669 unique patients, of whom 118 (7.1 %) were consented. Consented patients tended to be younger (65 ± 12 years) than those who refused consent (70 ± 14 years) (p = 0.007). Of the 1551 patients not consented, 1021 (65.8 %) were deemed ineligible. Compared to a full time research associate, the URMC EDRA program was cheaper and more productive.
The URMC EDRA program was highly effective in screening and consenting HF patients, successfully consenting 118 patients (14 per month). This is a significant achievement, especially given the study's strict inclusion and exclusion criteria. Compared to other studies and a full time research associate, the URMC EDRA program demonstrated remarkable productivity.
招募心力衰竭(HF)患者参与临床研究具有挑战性。急诊科(ED)可能会利用学生参与研究助理项目,比如罗切斯特大学医学中心(URMC)的急诊科研究助理(EDRA)项目,来筛选患者并获取其参与临床研究的同意。本文探讨了URMC的EDRA项目在使HF患者同意参与临床研究方面的有效性。
URMC的EDRA项目招募并获取了在URMC急诊科就诊的HF患者的同意。EDRA项目中的研究助理根据年龄(>18岁)和提示HF的主要症状来识别潜在患者。在识别出潜在患者后,会进行全面的病历审查,并且在患者同意参与研究之前,会与患者及主治医生讨论任何不确定因素。使用描述性统计来评估该项目的有效性。
在一个财政年度内,URMC的EDRA项目筛选了1669名不同患者,其中118名(7.1%)同意参与。同意参与的患者往往比拒绝同意的患者更年轻(65±12岁 vs 70±14岁)(p = 0.007)。在1551名未同意参与的患者中,1021名(65.8%)被认为不符合条件。与全职研究助理相比,URMC的EDRA项目成本更低且效率更高。
URMC的EDRA项目在筛选HF患者并获取其同意方面非常有效,成功使118名患者(每月14名)同意参与。这是一项重大成就,尤其是考虑到该研究严格的纳入和排除标准。与其他研究以及全职研究助理相比,URMC的EDRA项目展现出了显著的效率。